6:40 PM
 | 
Jun 10, 2008
 |  BC Extra  |  Top Story

Symphogen, Genentech in infectious deal

Symphogen (Copenhagen, Denmark) and Genentech (NYSE:DNA) partnered to develop antibody therapeutics to treat infectious disease. Symphogen will use its Symplex antibody discovery technology...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >